• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

继发性甲状旁腺功能亢进的外科治疗

Surgical management of secondary hyperparathyroidism.

作者信息

Olson John A, Leight George S

机构信息

Department of Surgery, Division of General Surgery, Duke University Medical Center, Durham, NC 27710, USA

出版信息

Adv Ren Replace Ther. 2002 Jul;9(3):209-18. doi: 10.1053/jarr.2002.34840.

DOI:10.1053/jarr.2002.34840
PMID:12203203
Abstract

Most patients with renal failure maintained on chronic dialysis have elevated parathyroid hormone (PTH) levels and PTH-mediated bone disease (secondary hyperparathyroidism [sHPT]). Elevated PTH production in this setting represents a progressive, exaggerated physiologic response to hypocalcemia by the parathyroid glands, and generalized growth of the parathyroids is an adaptive response to chronic stimulation. Effective medical strategies to reduce PTH secretion and PTH-mediated bone turnover in sHPT (eg, controlling hyperphosphatemia, normalizing serum calcium, and administering vitamin D analogs) has decreased the need for parathyroidectomy in recent years. However, failure of medical therapy because of inadequate treatment, persistent hyperphosphatemia, or acquired parathyroid neoplasia still leads to recommendations for parathyroidectomy in select patients. Furthermore, increased awareness of potential long-term, irreversible cardiovascular effects of uncorrected hyperparathyroidism has led some to advocate parathyroidectomy earlier in the course of this disease. This monograph will review parathyroidectomy for secondary and tertiary hyperparathyroidism.

摘要

大多数接受长期透析治疗的肾衰竭患者甲状旁腺激素(PTH)水平升高,存在PTH介导的骨病(继发性甲状旁腺功能亢进症[sHPT])。在这种情况下,PTH分泌增加代表甲状旁腺对低钙血症的一种渐进性、过度的生理反应,甲状旁腺的普遍增生是对慢性刺激的一种适应性反应。近年来,在sHPT中降低PTH分泌和PTH介导的骨转换的有效医学策略(如控制高磷血症、使血清钙正常化以及给予维生素D类似物)减少了甲状旁腺切除术的需求。然而,由于治疗不足、持续性高磷血症或获得性甲状旁腺肿瘤导致的药物治疗失败,仍然使得部分患者需要接受甲状旁腺切除术。此外,对未纠正的甲状旁腺功能亢进潜在的长期、不可逆心血管影响的认识增加,促使一些人主张在该病病程早期进行甲状旁腺切除术。本专著将综述继发性和三发性甲状旁腺功能亢进症的甲状旁腺切除术。

相似文献

1
Surgical management of secondary hyperparathyroidism.继发性甲状旁腺功能亢进的外科治疗
Adv Ren Replace Ther. 2002 Jul;9(3):209-18. doi: 10.1053/jarr.2002.34840.
2
Kidney Disease Improving Global Outcomes guidelines and parathyroidectomy for renal hyperparathyroidism.改善全球肾脏病预后组织(KDIGO)指南与肾性甲状旁腺功能亢进的甲状旁腺切除术
J Surg Res. 2015 Nov;199(1):115-20. doi: 10.1016/j.jss.2015.04.046. Epub 2015 Apr 18.
3
Parathyroidectomy in dialysis patients: Indications, methods, and consequences.透析患者的甲状旁腺切除术:适应症、方法及后果
Semin Dial. 2019 Sep;32(5):444-451. doi: 10.1111/sdi.12772. Epub 2019 Jan 17.
4
Calcimimetics versus parathyroidectomy: What is preferable?拟钙剂与甲状旁腺切除术:哪种更可取?
Int Urol Nephrol. 2018 Jul;50(7):1271-1275. doi: 10.1007/s11255-018-1838-5. Epub 2018 Mar 12.
5
Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism.继发性甲状旁腺功能亢进透析患者全甲状旁腺切除术后饥饿骨综合征的危险因素及临床病程
BMC Nephrol. 2017 Jan 10;18(1):12. doi: 10.1186/s12882-016-0421-5.
6
Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.盐酸西那卡塞:一种治疗慢性肾脏病所致继发性甲状旁腺功能亢进的新疗法。
J Ren Nutr. 2006 Jul;16(3):253-8. doi: 10.1053/j.jrn.2006.04.010.
7
[Treatment of secondary and tertiary hyperparathyroidism--surgical viewpoints].[继发性和三发性甲状旁腺功能亢进的治疗——外科观点]
Chirurg. 1999 Oct;70(10):1089-101. doi: 10.1007/s001040050870.
8
[Clinical study of parathyroidectomy of secondary hyperparathyroidism in patients with chronic renal failure].慢性肾功能衰竭患者继发性甲状旁腺功能亢进甲状旁腺切除术的临床研究
Hinyokika Kiyo. 1992 May;38(5):541-7.
9
Surgical Management of Secondary and Tertiary Hyperparathyroidism.继发性和三发性甲状旁腺功能亢进的手术治疗。
Surg Clin North Am. 2024 Aug;104(4):825-835. doi: 10.1016/j.suc.2024.02.011. Epub 2024 Mar 21.
10
A practical self-made device in parathyroid autotransplantation for patients with secondary hyperparathyroidism.一种为继发性甲状旁腺功能亢进患者自制的甲状旁腺自体移植实用装置。
J Int Med Res. 2019 Jan;47(1):59-65. doi: 10.1177/0300060518794840. Epub 2018 Sep 9.

引用本文的文献

1
RNA-Seq-based transcriptomics analysis during the photodynamic therapy of primary cells in secondary hyperparathyroidism.基于 RNA-Seq 的二代甲状旁腺功能亢进症原代细胞光动力治疗中转录组学分析。
Photochem Photobiol Sci. 2023 Apr;22(4):905-917. doi: 10.1007/s43630-023-00361-0. Epub 2023 Feb 7.
2
Evaluation of efficacy of ultrasound-guided microwave ablation in primary hyperparathyroidism.超声引导微波消融治疗原发性甲状旁腺功能亢进症的疗效评估。
J Clin Ultrasound. 2022 Feb;50(2):227-235. doi: 10.1002/jcu.23134. Epub 2022 Jan 5.
3
The pattern of the descent of PTH measured by intraoperative monitoring of intact-PTH in surgery for renal hyperparathyroidism.
在肾性甲状旁腺功能亢进手术中通过术中监测完整甲状旁腺激素(intact-PTH)所测得的甲状旁腺激素下降模式。
Indian J Surg. 2008 Apr;70(2):62-7. doi: 10.1007/s12262-008-0017-9. Epub 2008 May 21.
4
Public health approach to addressing hyperphosphatemia among dialysis patients.解决透析患者高磷血症的公共卫生方法。
J Ren Nutr. 2008 May;18(3):256-61. doi: 10.1053/j.jrn.2007.12.002.
5
Parathyroid subcutaneous pre-sternal transplantation after parathyroidectomy for renal hyperparathyroidism. Long-term graft function.肾性甲状旁腺功能亢进症甲状旁腺切除术后甲状旁腺胸骨前皮下移植。长期移植物功能。
World J Surg. 2007 Jul;31(7):1403-9. doi: 10.1007/s00268-007-9092-5. Epub 2007 May 22.
6
Intraoperative monitoring of intact PTH in surgery for renal hyperparathyroidism as an indicator of complete parathyroid removal.在肾性甲状旁腺功能亢进手术中对完整甲状旁腺激素进行术中监测,作为甲状旁腺完全切除的指标。
World J Surg. 2005 Nov;29(11):1504-9. doi: 10.1007/s00268-005-7862-5.